增强CT在术前评估非小细胞肺癌N1淋巴结转移中的诊断价值
Diagnostic Value of Enhanced CT in Preoperative Evaluation of N1 Lymph Node Metastasis in Non-Small Cell Lung Cancer
DOI: 10.12677/acm.2025.1582422, PDF,    科研立项经费支持
作者: 袁倩瑶*, 徐 锐, 韩 鹏, 钱运红, 吕梦宇, 赵 红#:安徽医科大学第二附属医院放射科,安徽 合肥
关键词: 非小细胞肺癌N1淋巴结转移增强CTNon-Small Cell Lung Cancer N1 Lymph Node Metastasis Enhanced CT
摘要: 目的:评价术前增强CT对非小细胞肺癌N1淋巴结转移的诊断价值。方法:选取2020年11月至2024年11月我院收治的160例经病理证实的NSCLC患者,根据有无N1淋巴结转移分为分N1 (+)组、N1 (−)组,分析比较两组患者临床、病理及影像特征的差异,采用Logistic回归及Lasso回归分析影响N1淋巴结转移的因素,并构建模型,采用受试者工作特征(ROC)曲线分析Logistic回归模型及Lasso回归模型对N1淋巴结转移的诊断价值;进一步构建诊断N1淋巴结转移的列线图并绘制校准曲线图进行内部验证。结果:多因素Logistic回归分析结果示,淋巴结短径和边界、病理肿瘤直径、脉管侵犯及病灶与支气管位置对N1淋巴结转移有较显著影响,其模型ROC曲线分析结果显示AUC值为0.929 (95% CI: 0.892~0.967),灵敏度为88.89%,特异度为83.33%,Lasso回归模型的AUC为0.9416 (95% CI: 0.9084~0.9749),与Logistic回归模型相比无显著差异(DeLong检验p = 0.10),提示Logistic模型诊断效能较好,总体效能优于单一短径标准(AUC值为0.864,灵敏度为76.3%,特异度为96.4% (95% CI: 0.801~0.926))。结论:基于淋巴结短径和边界、病理肿瘤直径、脉管侵犯及病灶与支气管位置构建的Logistic回归模型,相较于单一淋巴结短径诊断效能更好。
Abstract: Objective: To investigate the diagnostic value of enhanced CT in preoperative assessment of N1 lymph node metastasis in non-small cell lung cancer (NSCLC). Methods: A total of 160 patients with pathologically confirmed NSCLC admitted to our hospital from November 2020 to November 2024 were selected and divided into N1 (+) and N1 (−) groups based on the presence or absence of N1 lymph node metastasis. The differences in clinical, pathological, and imaging characteristics were analyzed and compared between two groups of patients. Logistic regression analysis and Lasso regression were used to identify factors influencing N1 lymph node metastasis, and models were constructed. The diagnostic value of the Logistic regression model and Lasso regression model for N1 lymph node metastasis was evaluated using receiver operating characteristic (ROC) curve analysis. Additionally, a nomogram for diagnosing N1 lymph node metastasis was constructed, and a calibration curve was plotted for internal validation. Results: Multivariate Logistic regression analysis revealed that lymph node short axis and margin, pathological tumor diameter, vascular invasion, and lesion location relative to the bronchus were independent factors influencing N1 lymph node metastasis. The ROC curve analysis of the Logistic regression model showed an AUC value of 0.929 (95% CI: 0.892~0.967), sensitivity of 88.89%, and specificity of 83.33%, The AUC of the LASSO regression model was 0.9416 (95% CI: 0.9084~0.9749), showing no significant difference compared to the Logistic regression model (DeLong test p = 0.10), indicating that the Logistic model has better diagnostic performance. The overall performance was superior to the single short diameter standard (AUC value of 0.864, sensitivity of 76.3%, specificity of 96.4% (95% CI: 0.801~0.926)). Conclusion: A Logistic regression model constructed based on lymph node short axis and margin, pathological tumor diameter, vascular invasion, and lesion location relative to the bronchus demonstrated better diagnostic performance than lymph node short axis alone.
文章引用:袁倩瑶, 徐锐, 韩鹏, 钱运红, 吕梦宇, 赵红. 增强CT在术前评估非小细胞肺癌N1淋巴结转移中的诊断价值[J]. 临床医学进展, 2025, 15(8): 1751-1761. https://doi.org/10.12677/acm.2025.1582422

参考文献

[1] 赵珂嘉, 刘成武, 刘伦旭. 《IASLC第九版肺癌TNM分期》解读[J]. 中国胸心血管外科临床杂志, 2024, 31(4): 489-497.
[2] 贺银付, 高德培. 非小细胞肺癌纵隔淋巴结转移的影像学评估现状[J]. 放射学实践, 2022, 37(1): 124-128.
[3] 赵方超, 李书军. 非小细胞肺癌纵隔淋巴结转移数学预测模型的建立与验证[J]. 现代肿瘤医学, 2021, 29(16): 2833-2837.
[4] 许颍, 李广利, 张申, 等. 18F-FDGPET/CT代谢参数在预测非小细胞肺癌患者纵隔淋巴结转移中的临床价值[J]. 国际放射医学核医学杂志, 2021, 45(8): 495-500.
[5] Huang, C., Tang, E., Shu, C., Chou, Y., Goan, Y. and Tseng, Y. (2023) Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-Small Cell Lung Cancer. Diagnostics, 13, Article 1399. [Google Scholar] [CrossRef] [PubMed]
[6] Manfredini, B., Zirafa, C.C., Stefani, A., Romano, G., Alì, G., Morganti, R., et al. (2025) Long-Term Oncological Outcomes Related to Lymphadenectomy in Clinical Stage I NSCLC: A Multicenter Retrospective Experience. Current Oncology, 32, Article 31. [Google Scholar] [CrossRef] [PubMed]
[7] 王晓燕, 何欣, 姚丽. 支气管超声弹性成像对肺门及纵隔淋巴结良恶性鉴别诊断的价值[J]. 实用癌症杂志, 2020, 35(7): 1207-1210.
[8] Yu, X., Wang, J., Huang, L., Xie, L. and Su, Y. (2024) Predictive Value of 18F-FDG PET/CT Metabolic Parameters for Lymph Node Metastasis of Non-Small Cell Lung Cancer. Biomarkers in Medicine, 19, 35-41. [Google Scholar] [CrossRef] [PubMed]
[9] 尹玲. 三期动态CT增强扫描在诊断右肺上叶肺癌及纵膈淋巴结转移中的临床价值研究[J]. 中国CT和MRI杂志, 2018, 16(5): 54-56, 93.
[10] 周跃. 袁双虎. 非小细胞肺癌纵隔淋巴结分期诊断研究进展[J]. 中华肿瘤防治杂志, 2017, 24(5): 344-349.
[11] 张磊, 米玉霞, 王建业. 术前多排螺旋CT三期增强扫描对非小细胞肺癌纵隔淋巴结转移的诊断价值[J]. 实用癌症杂志, 2024, 39(1): 83-86.
[12] 李盛旗, 涂伟岚, 王静. MSCT在肺癌伴肺门纵隔淋巴结转移诊断中的临床价值[J]. 医学理论与实践, 2024, 37(21): 3703-3705.
[13] 张锋, 石静滨. 非小细胞肺癌纵隔淋巴结转移CT与病理的一致性研究[J]. 现代肿瘤医学, 2014, 22(8): 1807-1810.
[14] 赵金龙, 田辉, 张凤伟. 早期非小细胞肺癌淋巴结转移的危险因素研究[J]. 中国临床医生杂志, 2023, 51(1): 20-23.
[15] 李向东, 尹吉林, 柳伟坤, 等. PET/CT对评价非小细胞肺癌纵隔淋巴结转移的诊断价值[J]. 南方医科大学学报, 2010, 30(3): 506-508.